HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

HENGRUI PHARMA

48.440

-0.700-1.42%

Volume:7.71M

Turnover:381.01M

Market Cap:321.50B

PE:35.06

High:51.000

Open:49.740

Low:48.280

Close:49.140

52wk High:91.880

52wk Low:43.020

Shares:6.64B

HK Float Shares:258.00M

Volume Ratio:1.56

T/O Rate:2.99%

Dividend:0.23

Dividend Rate:0.48%

EPS(LYR):1.381

ROE:12.46%

ROA:7.02%

PB:4.26

PE(LYR):35.06

PS:8.77

Loading ...

Overview Company News Filings

Hengrui Pharma's Unit Gets Nod to Trial HRS-1596 Tablets; Shares Down 3%

MT Newswires Live

Movement Alert｜HENGRUI PHARMA Falls 3.04% in Regular Trading, Pulling Back After Prior Sessions Strong Rally Amid Broad Sector Weakness

Jiangsu Hengrui Pharmaceuticals Secures Clinical Trial Approval for SHR-4595 Injection

Citi Highlights Policy Boost for Innovative Drugs and Medical Devices, Names Key Sector Picks

Movement Alert｜HENGRUI PHARMA Rises 3.11% in Regular Trading, Buyback Launched and Employee Stock Plan Unveiled Amid BlackRock Accumulation

HENGRUI PHARMA: BlackRock, Inc. Disposes, Long Position Falls to 6.99%

Hong Kong Stock Market Update | Hengrui Pharma Surges Nearly 4% on First A-Share Buyback as Analysts Eye Growth in Non-Oncology Portfolio

Movement Alert｜HENGRUI PHARMA Rises 3.78% in Regular Trading, First A-Share Buyback Executed as BlackRock Raises Stake to 7.68%

Blackrock's Long Position in H-Shares of Jiangsu Hengrui Pharmaceuticals Increases to 7.68% on Sept 14, HKEX Filing Shows

Hengrui Pharma Repurchases 335,000 A-Shares for ESOP at RMB 43.29 Each, Equal to 0.005% of Issued Capital

Bulletin Express

Jiangsu Hengrui Pharmaceuticals Completes Initial Share Repurchase, Investing 14.5 Million Yuan

HENGRUI PHARMA: BlackRock, Inc. Acquires Shares, Long Position Rises to 7.68%

Hong Kong Stock Market Update: Hengrui Pharma Surges Nearly 4% in Late Trading Following Dual Clinical Trial Approvals

China's Jiangsu Hengrui Climbs on Clinical Trial Approval for Stroke Drug

Hengrui Pharmaceuticals' Unit Gets Nod to Trial Recaticimab Injection

MT Newswires Live

Movement Alert｜HENGRUI PHARMA Rises 3.01% in Regular Trading, Dense Pipeline Milestones Boost Market Sentiment

BlackRock's Long Position in H-Shares of Jiangsu Hengrui Pharmaceuticals Increases to 7.17% on Sept 10 from 6.56% - HKEX

THOMSON REUTERS

Jiangsu Hengrui Secures Green Light for HRS-4139 Tablet Clinical Trials

Chinese Drug Regulator Accepts Hengrui Pharmaceuticals Unit's Marketing Application for SHR-2004 Injection

MT Newswires Live

Big Pharma is Pouring Billions into China's Biotechs

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/01276/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"01276","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01276\",,,,,undefined,":{"symbol":"01276","market":"HK","secType":"STK","nameCN":"HENGRUI PHARMA","latestPrice":48.44,"timestamp":1791446897003,"preClose":49.14,"halted":0,"volume":7707759,"delay":0,"changeRate":-0.014245014245014303,"floatShares":258000000,"shares":6637000000,"eps":1.3814376643252364,"marketStatus":"Not Yet Opened","change":-0.7,"latestTime":"10-08 16:08:17","open":49.74,"high":51,"low":48.28,"amount":381006025,"amplitude":0.055352,"askPrice":48.44,"askSize":30800,"bidPrice":48.4,"bidSize":200,"shortable":3,"etf":0,"ttmEps":1.3623433861005376,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1791509400000},"marketStatusCode":0,"adr":0,"listingDate":1747929600000,"exchange":"SEHK","adjPreClose":49.14,"dividendRate":0.004829,"openAndCloseTimeList":[[1791423000000,1791432000000],[1791435600000,1791446400000]],"volumeRatio":1.556397,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"600276","market":"SH","secType":"STK","nameCN":"Jiangsu Hengrui Pharmaceuticals Co.,Ltd.","latestPrice":47.01,"timestamp":1791442800000,"preClose":47.2,"halted":0,"volume":77344000,"delay":0,"premium":"-11.98"}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01276\",,,,,undefined,":{"symbol":"01276","floatShares":258000000,"roa":"7.02%","roe":"12.46%","lyrEps":1.381458,"volumeRatio":1.556397,"shares":6637000000,"dividePrice":0.234145,"high":51,"amplitude":0.055352,"preClose":49.14,"low":48.28,"week52Low":43.02,"pbRate":"4.26","psRate":"8.77","week52High":91.88,"institutionHeld":0,"latestPrice":48.44,"committee":-0.987097,"eps":1.3814577675922581,"divideRate":0.004834,"volume":7707759,"delay":0,"ttmEps":1.362363211499521,"open":49.74,"prevYearClose":71.002,"prevWeekClose":49.66,"prevMonthClose":50.2,"prevQuarterClose":50.2,"fiveDayClose":50.2,"twentyDayClose":45.94,"sixtyDayClose":58.45,"earningDate":1793116800000},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/01276\",params:#limit:5,,,undefined,":[{"date":"2026-10-28","symbol":"01276","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1793151000000,"name":null,"time":"","dateTimestamp":1793116800000,"actualEps":null},{"date":"2026-08-19","symbol":"01276","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787103000000,"name":null,"time":"","dateTimestamp":1787068800000,"actualEps":null},{"date":"2026-04-29","symbol":"01276","amount":0.22828,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"HK","newRecordDate":"2026-04-30","defaultRemindTime":1777426200000,"name":"恒瑞医药","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-05-27","payableDate":"2026-04-30","currency":"HKD","dateTimestamp":1777392000000,"payDate":"2026-05-27"},{"date":"2026-04-22","symbol":"01276","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1776821400000,"name":null,"time":"","dateTimestamp":1776787200000,"actualEps":null},{"date":"2026-03-26","symbol":"01276","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774488600000,"name":null,"time":"","dateTimestamp":1774454400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"01276\",market:\"HK\",,,undefined,":[{"executeDate":"2026-04-29","recordDate":"2026-04-30","paymentDate":"2026-05-27","value":0.22828,"currency":"HKD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"01276\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.2727,"buy":0.5455,"hold":0.1818,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5455,"analysts":11,"updateTime":1786723200000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/01276\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"01276","date":"2026-10-07","current":35.555863,"percent":0.138235,"low":36.382401,"twenty":43.078413,"median":51.356483,"eighty":56.807294,"high":65.582363,"avg":50.578041,"sd":7.710556,"marketCap":364150510612.46},"quantilePoints":[{"date":"2025-05-23","current":52.570963,"twenty":52.783176,"median":53.101495,"eighty":53.419815,"marketCap":390693388207.53},{"date":"2025-05-30","current":53.015805,"twenty":51.822085,"median":52.540895,"eighty":52.926837,"marketCap":395731540422.24},{"date":"2025-06-06","current":52.120101,"twenty":52.130014,"median":52.555929,"eighty":53.075252,"marketCap":390038198012.59},{"date":"2025-06-13","current":52.209491,"twenty":52.177631,"median":52.691227,"eighty":53.357137,"marketCap":390861633032.23},{"date":"2025-06-20","current":50.172412,"twenty":51.591196,"median":52.469796,"eighty":53.075252,"marketCap":374874997562.85},{"date":"2025-06-27","current":50.314776,"twenty":50.363569,"median":52.169666,"eighty":53.013533,"marketCap":376991477472.78},{"date":"2025-07-04","current":51.666141,"twenty":50.343584,"median":52.120101,"eighty":53.004446,"marketCap":387134991658.26},{"date":"2025-07-11","current":55.507007,"twenty":50.44351,"median":52.13337,"eighty":53.090114,"marketCap":415495681161.23},{"date":"2025-07-18","current":57.272274,"twenty":50.582121,"median":52.209491,"eighty":54.057606,"marketCap":428373566715.29},{"date":"2025-07-25","current":54.897923,"twenty":50.594414,"median":52.555929,"eighty":55.711415,"marketCap":412107620053.2},{"date":"2025-08-01","current":59.731878,"twenty":50.855059,"median":52.994419,"eighty":55.972407,"marketCap":445624526286.47},{"date":"2025-08-08","current":59.478715,"twenty":51.107295,"median":53.05296,"eighty":56.541585,"marketCap":444845815775.64},{"date":"2025-08-15","current":61.917611,"twenty":51.356483,"median":53.519848,"eighty":59.478715,"marketCap":462392609292.46},{"date":"2025-08-22","current":58.782188,"twenty":51.569512,"median":54.477764,"eighty":60.15932,"marketCap":470428104569.66},{"date":"2025-08-29","current":59.85298,"twenty":51.666141,"median":55.691374,"eighty":59.937003,"marketCap":481284287403.35},{"date":"2025-09-05","current":65.582363,"twenty":51.677932,"median":55.770266,"eighty":60.732448,"marketCap":526832269752.24},{"date":"2025-09-12","current":62.481332,"twenty":51.8337,"median":55.972407,"eighty":61.285609,"marketCap":502824785657.99},{"date":"2025-09-19","current":63.179889,"twenty":52.120101,"median":56.254853,"eighty":61.852995,"marketCap":508085671393.42},{"date":"2025-09-26","current":63.528382,"twenty":52.146639,"median":56.965096,"eighty":62.270337,"marketCap":509562668601.01},{"date":"2025-10-03","current":64.989073,"twenty":52.165061,"median":57.272274,"eighty":62.504861,"marketCap":522523002865.02},{"date":"2025-10-10","current":61.782766,"twenty":52.193561,"median":59.039802,"eighty":62.657943,"marketCap":496019912951.91},{"date":"2025-10-17","current":58.903713,"twenty":52.323014,"median":59.170669,"eighty":62.619084,"marketCap":472537436949.31},{"date":"2025-10-24","current":59.187086,"twenty":52.484015,"median":59.039802,"eighty":62.52839,"marketCap":474983377696.11},{"date":"2025-10-31","current":57.072441,"twenty":52.552922,"median":59.021138,"eighty":62.417499,"marketCap":465758305542.93},{"date":"2025-11-07","current":54.713071,"twenty":52.619069,"median":58.881843,"eighty":62.304573,"marketCap":446224987036.64},{"date":"2025-11-14","current":55.883072,"twenty":52.812504,"median":58.231971,"eighty":62.27542,"marketCap":457058673340.29},{"date":"2025-11-21","current":52.805265,"twenty":52.880927,"median":57.030538,"eighty":62.209511,"marketCap":431684582485.14},{"date":"2025-11-28","current":55.237621,"twenty":52.99843,"median":56.630614,"eighty":62.069705,"marketCap":453209419829.34},{"date":"2025-12-05","current":54.841023,"twenty":53.00899,"median":56.437545,"eighty":61.965159,"marketCap":450729029423.46},{"date":"2025-12-12","current":56.212257,"twenty":53.045529,"median":56.385682,"eighty":61.891765,"marketCap":462853512587.19},{"date":"2025-12-19","current":54.083493,"twenty":53.045529,"median":56.227363,"eighty":61.831221,"marketCap":446374731108.34},{"date":"2025-12-24","current":54.414957,"twenty":53.090114,"median":56.103073,"eighty":61.798561,"marketCap":450509359276.9},{"date":"2026-01-02","current":53.078544,"twenty":53.065996,"median":55.972407,"eighty":61.785925,"marketCap":441174507319.22},{"date":"2026-01-09","current":56.743223,"twenty":53.0878,"median":56.0944,"eighty":61.695241,"marketCap":472808676524.34},{"date":"2026-01-16","current":55.187351,"twenty":53.304215,"median":56.103073,"eighty":61.405393,"marketCap":461338821289.95},{"date":"2026-01-23","current":52.546341,"twenty":53.0878,"median":56.076447,"eighty":61.296167,"marketCap":438839874056.97},{"date":"2026-01-30","current":51.677141,"twenty":52.994149,"median":55.908509,"eighty":61.278475,"marketCap":433553740508.2},{"date":"2026-02-06","current":50.918226,"twenty":52.680723,"median":55.839154,"eighty":61.101743,"marketCap":428270226283.58},{"date":"2026-02-13","current":51.771686,"twenty":52.512455,"median":55.711415,"eighty":60.890064,"marketCap":437949787160.49},{"date":"2026-02-20","current":51.752043,"twenty":52.351169,"median":55.691374,"eighty":60.824953,"marketCap":437153052005.04},{"date":"2026-02-27","current":50.215456,"twenty":52.151244,"median":55.507566,"eighty":60.720339,"marketCap":428825318404.97},{"date":"2026-03-06","current":49.335298,"twenty":51.80347,"median":55.280584,"eighty":60.654676,"marketCap":417912584744.19},{"date":"2026-03-13","current":48.90444,"twenty":51.75217,"median":55.201025,"eighty":60.572606,"marketCap":416170839186.33},{"date":"2026-03-20","current":48.948437,"twenty":51.671435,"median":55.086674,"eighty":60.515374,"marketCap":414967977646.95},{"date":"2026-03-27","current":47.483832,"twenty":51.400677,"median":54.94883,"eighty":60.443129,"marketCap":414588875872.42},{"date":"2026-04-02","current":49.302243,"twenty":51.107295,"median":54.905743,"eighty":60.227005,"marketCap":432534434303.11},{"date":"2026-04-10","current":49.055344,"twenty":50.995993,"median":54.897923,"eighty":60.186394,"marketCap":433687668394.36},{"date":"2026-04-17","current":48.417764,"twenty":50.589497,"median":54.65026,"eighty":60.143018,"marketCap":428230701835.75},{"date":"2026-04-24","current":45.835792,"twenty":50.342877,"median":54.475147,"eighty":60.015062,"marketCap":426879682872.04},{"date":"2026-04-30","current":44.026312,"twenty":50.285416,"median":54.355253,"eighty":59.903394,"marketCap":410132737659.64},{"date":"2026-05-08","current":43.161515,"twenty":50.207478,"median":54.262074,"eighty":59.804539,"marketCap":403472171949.3},{"date":"2026-05-15","current":44.128138,"twenty":49.985706,"median":54.115335,"eighty":59.70386,"marketCap":413593092820.6},{"date":"2026-05-22","current":41.244553,"twenty":49.583265,"median":53.983854,"eighty":59.631568,"marketCap":385683097978.4},{"date":"2026-05-29","current":40.98659,"twenty":49.34142,"median":53.840414,"eighty":59.564678,"marketCap":384603594259.51},{"date":"2026-06-05","current":38.394132,"twenty":49.063316,"median":53.633194,"eighty":59.459458,"marketCap":360799766229.36},{"date":"2026-06-12","current":39.515262,"twenty":48.81081,"median":53.517715,"eighty":59.36625,"marketCap":371084155232.86},{"date":"2026-06-18","current":39.444808,"twenty":48.417764,"median":53.467699,"eighty":59.301536,"marketCap":371311256576.18},{"date":"2026-06-26","current":39.60241,"twenty":47.951326,"median":53.090114,"eighty":59.187086,"marketCap":370974287810.31},{"date":"2026-07-03","current":44.319925,"twenty":47.638943,"median":53.015805,"eighty":59.069259,"marketCap":415476044901.86},{"date":"2026-07-10","current":45.319748,"twenty":47.348429,"median":52.993744,"eighty":59.024871,"marketCap":424327469311.14},{"date":"2026-07-17","current":43.189222,"twenty":46.151454,"median":52.805265,"eighty":58.96135,"marketCap":405818502739.33},{"date":"2026-07-24","current":43.433009,"twenty":45.632553,"median":52.604835,"eighty":58.912251,"marketCap":408200902707.63},{"date":"2026-07-31","current":43.935338,"twenty":45.29749,"median":52.543618,"eighty":58.877468,"marketCap":413706414238.87},{"date":"2026-08-07","current":44.394532,"twenty":45.008473,"median":52.339287,"eighty":58.813302,"marketCap":418841988303.56},{"date":"2026-08-14","current":42.6704,"twenty":44.628794,"median":52.189578,"eighty":58.452058,"marketCap":403085247281.44},{"date":"2026-08-21","current":40.686911,"twenty":44.408765,"median":52.120101,"eighty":57.75211,"marketCap":366558497066.13},{"date":"2026-08-28","current":40.334802,"twenty":44.24321,"median":51.814807,"eighty":57.336246,"marketCap":363468645736.13},{"date":"2026-09-04","current":39.220129,"twenty":44.050964,"median":51.771686,"eighty":57.152374,"marketCap":353565883607.49},{"date":"2026-09-11","current":36.382401,"twenty":43.912617,"median":51.717719,"eighty":57.022157,"marketCap":328426636361.34},{"date":"2026-09-18","current":37.472943,"twenty":43.707258,"median":51.677141,"eighty":56.974512,"marketCap":338713028678.65},{"date":"2026-09-25","current":38.226655,"twenty":43.43262,"median":51.617827,"eighty":56.891919,"marketCap":344867204477.93},{"date":"2026-10-02","current":40.279147,"twenty":43.172598,"median":51.438629,"eighty":56.828798,"marketCap":363767175425.28},{"date":"2026-10-07","current":40.264098,"twenty":43.078413,"median":51.356483,"eighty":56.807294,"marketCap":364150510612.46}],"updateTime":1791480149670},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"01276\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2669197087","title":"Hengrui Pharma's Unit Gets Nod to Trial HRS-1596 Tablets; Shares Down 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669197087","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669197087?lang=en_us&edition=fundamental","pubTime":"2026-09-22 10:40","pubTimestamp":1790044833,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals'  unit, Fujian Shengdi Pharmaceutical, received approval from China's National Medical Products Administration to conduct clinical trials on HRS-1596 tablets, according to a Tuesday disclosure on the Shanghai bourse.The drug will be tested as a weight management product and as a treatment for type 2 diabetes mellitus.The pharmaceutical company's Hong Kong shares fell 3% and Shanghai shares slipped 1% during the morning trade.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2543165471.USD","LU0359201612.USD","LU0359201885.HKD","BK1191","LU0359202008.SGD","LU1023057109.AUD","01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162211536","title":"Movement Alert｜HENGRUI PHARMA Falls 3.04% in Regular Trading, Pulling Back After Prior Sessions Strong Rally Amid Broad Sector Weakness","url":"https://stock-news.laohu8.com/highlight/detail?id=1162211536","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162211536?lang=en_us&edition=fundamental","pubTime":"2026-09-22 09:57","pubTimestamp":1790042227,"startTime":"0","endTime":"0","summary":"On September 22, HENGRUI PHARMA declined 3.04% in regular trading, trading at HK$48.0/share, with turnover of HK$60.72 million. The pullback follows a sharp rally of over 6% in the prior session,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Hengrui Pharma Falls as Citi, BofA Rally Fades","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174623645","title":"Jiangsu Hengrui Pharmaceuticals Secures Clinical Trial Approval for SHR-4595 Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=1174623645","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174623645?lang=en_us&edition=fundamental","pubTime":"2026-09-21 16:56","pubTimestamp":1789980976,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals Co.,Ltd. (SH: 600276) has announced that its subsidiary, Suzhou Sdiary Biopharmaceuticals Co., Ltd., recently obtained the Clinical Trial Approval Notice for the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDTX","IBBQ","LU1064130708.USD","LU1820825898.SGD","01276","LU2289578879.USD","LU2495084118.USD","BK0196","LU1064131003.USD","PSYK","LU1146622755.USD","LU2488822045.USD","IBBJ","LU1969619763.USD","LU0405327494.USD","LU1997244956.HKD","LU0405327148.USD","BMED","LU1655091616.SGD","BK0188","600276","LU1997245094.SGD","LU0359201612.USD","LU2328871848.SGD","LU1328615791.USD","BK1191","LU2543165471.USD","LU2580892789.USD","LU1997245177.USD","BK0183","LU1255011170.USD","LU1781817850.SGD","LU2097828557.USD","BK0012","LU2097828474.EUR","LU2097828805.USD","BK0028","LU2148510915.USD","LU0359201885.HKD","BK0239","LU1580142542.USD","LU2097828631.EUR","LU1023057109.AUD","LU0359202008.SGD","BK0060","LU2097828714.EUR","LU2580892862.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112501840","title":"Citi Highlights Policy Boost for Innovative Drugs and Medical Devices, Names Key Sector Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=1112501840","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112501840?lang=en_us&edition=fundamental","pubTime":"2026-09-21 15:17","pubTimestamp":1789975044,"startTime":"0","endTime":"0","summary":"Citi has issued a research report following the joint release of the 15th Five-Year Plan for the Pharmaceutical Industry Development by the Ministry of Industry and Information Technology and other...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","LU0456846285.SGD","LU2360032135.SGD","FTXO","BK1610","LU0203345920.USD","LU0516422366.SGD","LU2543165471.USD","BK1515","LU2125154935.USD","LU3063872942.SGD","LU1226287529.USD","LU0880133367.SGD","LU0540923850.HKD","LU2097828714.EUR","LU0128526141.USD","BK4566","GDOC","LU1152091168.USD","IE00BSNM7G36.USD","IE00B5MMRT66.SGD","BK1100","LU0130102774.USD","IE00B031HY20.USD","LU2097828557.USD","LU0029874905.USD","LU0052750758.USD","BK4559","01801","SG9999002562.SGD","LU2242644610.SGD","LU0823426480.USD","LU0072461881.USD","BK1576","LU1794554557.SGD","06978","IE00BZ08YT58.USD","LU1791807156.HKD","LU2328871848.SGD","LU0516422952.EUR","LU0128522744.USD","IE00B543WZ88.USD","MEDX","LU0572944931.SGD","09996","LU1074936037.SGD","LU1152091754.HKD","IEIH","LU0181495838.USD","LU1993786604.SGD","LU0072913022.USD","LU0130517989.USD","LGHT","LU0516423174.USD","LU0417516902.SGD","LU1880383366.USD","LU0203347892.USD","BK1574","LU1969619763.USD","LU1688375341.USD","01093","IYF","LU1244550494.USD","LU0348827113.USD","BK4534","BK4585","LU1328277881.USD","BK1191","LU0320764243.SGD","LU0320765646.SGD","LU1668664300.SGD","LU1226287875.USD","LU1242518857.USD","BK1589","LU0106831901.USD","LU0162691827.USD","LU1008478684.HKD","LU2097828631.EUR","159992","LU0516422440.USD","LU1144417596.USD","LU1226288170.HKD","LU1960683339.HKD","LU0979878070.USD","IE00BZ08YR35.GBP","LU0067412154.USD","LU0477156953.USD","HK0000165453.HKD","LU0196878994.USD","LU0348825331.USD","BK1161","LU0310800965.SGD","LU0315179316.USD","LU0043850808.USD","LU0140636845.USD","SG9999004220.SGD","LU0327786744.USD","LU1201861249.SGD","LU0314109678.HKD","LU1244550577.SGD","LU1162221912.USD","LU0348735423.USD","LU0417516738.SGD","LU0980610538.SGD","LU0029874061.USD","LU2039709279.SGD","HART","KURE","03347","LU2125154778.USD","LU0307460666.USD","MDEV","LU0708995153.HKD","LU2097828805.USD","IE00B0JY6N72.USD","BK1521","LU2456880835.USD","LU0098860793.USD","LU0516423091.SGD","LU2417539215.USD","159883","LU1023057109.AUD","LU1226288253.USD","LU1242518931.SGD","LU1807302812.USD","BK4588","LU1366192091.USD","IE00BZ08YS42.EUR","02269","LU0502904849.HKD","LU1226287792.SGD","PTH","LU0320764599.SGD","SG9999002463.SGD","LU0359201885.HKD","LU1506573853.SGD","LU0455707207.USD","RSPH","C","TFNS","LU0359201612.USD","LU0501845795.SGD","BK1583","LU0359202008.SGD","LU0823426308.USD","LU2097828474.EUR","LU2236285917.USD","AGNG","LU0648001328.SGD","LU0708995583.HKD","LU0819121731.USD","LU0856984785.SGD","LU1813983027.USD","LU2462157665.USD","LU0051755006.USD","LU1720050803.USD","BK4207","LNGR","LU1951186391.HKD","IE0008368742.USD","LU0128525689.USD","LU0314106906.USD","LU1188198961.HKD","BK1141","LU0607220059.USD","01276","LU0149534421.HKD","LU0170899867.USD","LU0463099449.HKD","LU1831875114.USD","LU0456827905.SGD","LU1267930227.SGD","LU0052756011.USD","LU0588546209.SGD","LU0039217434.USD","06990","LU0561508036.HKD","BK4504","LU0634319403.HKD","LU2488822045.USD","LU0326950275.SGD","IE0008369823.USD","LU0244354667.USD","LU1244550221.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132658334","title":"Movement Alert｜HENGRUI PHARMA Rises 3.11% in Regular Trading, Buyback Launched and Employee Stock Plan Unveiled Amid BlackRock Accumulation","url":"https://stock-news.laohu8.com/highlight/detail?id=1132658334","media":"Market Focus","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132658334?lang=en_us&edition=fundamental","pubTime":"2026-09-21 09:48","pubTimestamp":1789955285,"startTime":"0","endTime":"0","summary":"On September 21, HENGRUI PHARMA rose 3.11% in regular trading to HKD 47.68, with turnover of HKD 74.67 million. The rally follows a cluster of positive catalysts disclosed late last week.On September...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"HENGRUI PHARMA Rises on Buyback and Employee Stock Plan","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173720732","title":"HENGRUI PHARMA: BlackRock, Inc. Disposes, Long Position Falls to 6.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=1173720732","media":"HK Disclosure","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173720732?lang=en_us&edition=fundamental","pubTime":"2026-09-18 17:43","pubTimestamp":1789724583,"startTime":"0","endTime":"0","summary":"On September 15, 2026, BlackRock, Inc. disposed of 1.92 million H shares of HENGRUI PHARMA (01276) off-exchange, as it no longer held a security interest in the shares; the transaction involved...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141777633","title":"Hong Kong Stock Market Update | Hengrui Pharma Surges Nearly 4% on First A-Share Buyback as Analysts Eye Growth in Non-Oncology Portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=1141777633","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141777633?lang=en_us&edition=fundamental","pubTime":"2026-09-18 10:20","pubTimestamp":1789698017,"startTime":"0","endTime":"0","summary":"HENGRUI PHARMA (01276) climbed nearly 4% in Hong Kong trading, with shares last up 3.2% at HK$45.80, on turnover of HK$59.53 million.The move follows the company's announcement that it spent RMB...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1064130708.USD","03188","83130","BK0196","LU2097828714.EUR","LU2580892789.USD","BK1191","BK0028","LU1655091616.SGD","83188","07233","LU2289578879.USD","BK1147","LU0405327494.USD","LU1781817850.SGD","BK4585","LU2097828557.USD","LU2543165471.USD","KCAI","LU1997245177.USD","02846","LU0405327148.USD","BK0188","LU1146622755.USD","LU1328615791.USD","LU1580142542.USD","LU2097828474.EUR","03130","LU2097828805.USD","02827","LU2148510915.USD","399300","BK0239","LU1997245094.SGD","LU1064131003.USD","LU2328871848.SGD","LU2580892862.HKD","BK0012","BK0060","LU0359201885.HKD","LU0359202008.SGD","LU1997244956.HKD","LU2488822045.USD","159982","LU2495084118.USD","82846","BK4588","600276","LU1820825898.SGD","LU1023057109.AUD","LU0359201612.USD","LU1255011170.USD","LU1969619763.USD","LU2097828631.EUR","VXUS","BK0183","01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198866464","title":"Movement Alert｜HENGRUI PHARMA Rises 3.78% in Regular Trading, First A-Share Buyback Executed as BlackRock Raises Stake to 7.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=1198866464","media":"Market Focus","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198866464?lang=en_us&edition=fundamental","pubTime":"2026-09-18 09:59","pubTimestamp":1789696756,"startTime":"0","endTime":"0","summary":"On September 18, HENGRUI PHARMA rose 3.78% in regular trading, trading at HKD 46.02/share, with turnover of HKD 47.53 million.On the news front, the company disclosed on September 17 that it...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Hengrui Pharma Rises as First Buyback Done, BlackRock Ups Stake","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668996838","title":"Blackrock's Long Position in H-Shares of Jiangsu Hengrui Pharmaceuticals Increases to 7.68% on Sept 14, HKEX Filing Shows","url":"https://stock-news.laohu8.com/highlight/detail?id=2668996838","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668996838?lang=en_us&edition=fundamental","pubTime":"2026-09-17 23:50","pubTimestamp":1789660240,"startTime":"0","endTime":"0","summary":"BRIEF-Blackrock's Long Position In H-Shares Of Jiangsu Hengrui Pharmaceuticals Increases To 7.68% On Sept 14, HKEX Filing ShowsSept 17 (Reuters)-HKEX:BLACKROCK'S LONG POSITION IN H-SHARES OF JIANGSU HENGRUI PHARMACEUTICALS INCREASES TO 7.68% ON SEPT 14Further company coverage:1276.HK","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nFWN45909J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2097828557.USD","LU0359201612.USD","BK1191","LU1655091616.SGD","LU1997245177.USD","LU2495084118.USD","LU2097828474.EUR","BK0196","LU1146622755.USD","LU1328615791.USD","LU1820825898.SGD","LU2148510915.USD","LU0405327494.USD","LU1997245094.SGD","LU2328871848.SGD","LU2289578879.USD","LU1064130708.USD","LU2543165471.USD","LU2097828714.EUR","LU1969619763.USD","BK0183","LU2580892862.HKD","LU2488822045.USD","LU1064131003.USD","LU2580892789.USD","01276","BK0028","LU0405327148.USD","LU1255011170.USD","LU1023057109.AUD","BK0239","BK0188","BK0060","LU0359201885.HKD","LU1997244956.HKD","LU1781817850.SGD","LU2097828631.EUR","LU1580142542.USD","BK0012","LU0359202008.SGD","600276","LU2097828805.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150135700","title":"Hengrui Pharma Repurchases 335,000 A-Shares for ESOP at RMB 43.29 Each, Equal to 0.005% of Issued Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=1150135700","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150135700?lang=en_us&edition=fundamental","pubTime":"2026-09-17 19:43","pubTimestamp":1789645419,"startTime":"0","endTime":"0","summary":"On 17 September 2026, Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma) executed an on-market buy-back of 335,000 A-shares on the Shanghai Stock Exchange to support its A-Share Employee...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148606058","title":"Jiangsu Hengrui Pharmaceuticals Completes Initial Share Repurchase, Investing 14.5 Million Yuan","url":"https://stock-news.laohu8.com/highlight/detail?id=1148606058","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148606058?lang=en_us&edition=fundamental","pubTime":"2026-09-17 17:24","pubTimestamp":1789637056,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals Co., Ltd. (600276.SH) has announced its first buyback of A-shares, executed through centralized bidding transactions on September 17, 2026.During this transaction, the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2580892862.HKD","BK1191","BK0060","LU2097828805.USD","BK0188","LU0359201612.USD","BK0239","LU1328615791.USD","LU0359202008.SGD","LU1997245177.USD","600276","01276","LU1064130708.USD","LU1820825898.SGD","LU1023057109.AUD","LU2097828631.EUR","LU2543165471.USD","LU1255011170.USD","LU1781817850.SGD","LU1655091616.SGD","BK0196","BK0183","LU1997244956.HKD","LU2580892789.USD","LU2097828474.EUR","LU2289578879.USD","LU1146622755.USD","LU0359201885.HKD","LU2148510915.USD","LU2488822045.USD","LU2097828714.EUR","LU2328871848.SGD","LU0405327148.USD","BK0028","LU1969619763.USD","LU2495084118.USD","LU2097828557.USD","LU0405327494.USD","BK0012","LU1064131003.USD","LU1997245094.SGD","LU1580142542.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148962826","title":"HENGRUI PHARMA: BlackRock, Inc. Acquires Shares, Long Position Rises to 7.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=1148962826","media":"HK Disclosure","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148962826?lang=en_us&edition=fundamental","pubTime":"2026-09-17 17:14","pubTimestamp":1789636453,"startTime":"0","endTime":"0","summary":"On September 14, 2026, BlackRock, Inc. acquired 2.63 million H shares of HENGRUI PHARMA (01276) by way of taking a security interest in shares off-exchange, with consideration being non-cash assets....","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177370867","title":"Hong Kong Stock Market Update: Hengrui Pharma Surges Nearly 4% in Late Trading Following Dual Clinical Trial Approvals","url":"https://stock-news.laohu8.com/highlight/detail?id=1177370867","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177370867?lang=en_us&edition=fundamental","pubTime":"2026-09-16 15:52","pubTimestamp":1789545137,"startTime":"0","endTime":"0","summary":"HENGRUI PHARMA (01276) saw its shares climb nearly 4% during the final stretch of Thursday's trading session, buoyed by regulatory approvals for two distinct clinical programs targeting separate...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1023057109.AUD","BK0196","PSYK","LU2097828557.USD","LU2328871848.SGD","BK0060","LU2495084118.USD","LU2097828805.USD","LU2488822045.USD","IBBJ","LU2580892862.HKD","LU0359201885.HKD","LU2543165471.USD","LU1255011170.USD","BMED","LU1064131003.USD","LU1969619763.USD","LU1997245094.SGD","LU2097828714.EUR","VXUS","BK4588","LU1997245177.USD","LU0405327494.USD","LU1820825898.SGD","LU2580892789.USD","LU1655091616.SGD","LU1328615791.USD","LU0359202008.SGD","BK1191","IBBQ","BK0012","LU0405327148.USD","LU2148510915.USD","01276","600276","LU1580142542.USD","LU0359201612.USD","BK0239","LU1781817850.SGD","LU2097828631.EUR","BK4585","LU1064130708.USD","MDTX","LU2097828474.EUR","BK0183","LU1997244956.HKD","KCAI","LU1146622755.USD","LU2289578879.USD","BK0188","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667603734","title":"China's Jiangsu Hengrui Climbs on Clinical Trial Approval for Stroke Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2667603734","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667603734?lang=en_us&edition=fundamental","pubTime":"2026-09-16 15:38","pubTimestamp":1789544325,"startTime":"0","endTime":"0","summary":"BUZZ-China's Jiangsu Hengrui climbs on clinical trial approval for stroke drug** Hong Kong shares of Jiangsu Hengrui Pharmaceuticals1276.HKclimb 3.5% to HK$45.34, on course for the biggest one-day pct","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nL1N45806E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1255011170.USD","600276","BK0183","LU2289578879.USD","LU2097828557.USD","LU2097828714.EUR","LU1580142542.USD","LU2543165471.USD","BK0060","LU0359201612.USD","BK0188","LU1328615791.USD","01276","LU1064130708.USD","LU2148510915.USD","BK0028","LU2097828474.EUR","LU2495084118.USD","LU0405327494.USD","LU1023057109.AUD","LU1146622755.USD","LU1820825898.SGD","LU1997245177.USD","LU1064131003.USD","LU2580892862.HKD","LU1997245094.SGD","LU2097828805.USD","LU2488822045.USD","LU2328871848.SGD","LU1781817850.SGD","BK0196","LU1997244956.HKD","BK0012","LU0405327148.USD","LU2580892789.USD","LU1969619763.USD","BK1191","LU0359201885.HKD","LU2097828631.EUR","LU1655091616.SGD","LU0359202008.SGD","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667679529","title":"Hengrui Pharmaceuticals' Unit Gets Nod to Trial Recaticimab Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=2667679529","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667679529?lang=en_us&edition=fundamental","pubTime":"2026-09-16 10:29","pubTimestamp":1789525750,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals  unit, Guangdong Hengrui Pharmaceutical, received approval from China's National Medical Products Administration for the clinical trial of recaticimab injection, according to a Shanghai bourse filing on Wednesday.The drug is used to treat adult patients with intracranial atherosclerotic stenosis to reduce the risk of recurrent stroke.The pharmaceutical company invested 422.2 million yuan into the research and development of the drug.The company's Hong Kong shares rose 2% during the morning trade.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2495084118.USD","LU0359202008.SGD","LU1781817850.SGD","LU1997245094.SGD","LU0405327148.USD","LU2543165471.USD","LU2097828557.USD","LU1820825898.SGD","LU1969619763.USD","LU2097828631.EUR","LU2328871848.SGD","BK0028","LU1064131003.USD","LU0405327494.USD","LU1064130708.USD","LU2148510915.USD","LU2097828474.EUR","BK0196","LU1328615791.USD","600276","LU2580892789.USD","BK0012","LU2488822045.USD","BK0188","LU2580892862.HKD","LU1580142542.USD","LU0359201885.HKD","LU1655091616.SGD","LU1023057109.AUD","LU0359201612.USD","LU2289578879.USD","BK0183","LU1997245177.USD","LU1255011170.USD","BK0239","01276","LU2097828714.EUR","LU1146622755.USD","LU2097828805.USD","BK1191","BK0060","LU1997244956.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111961748","title":"Movement Alert｜HENGRUI PHARMA Rises 3.01% in Regular Trading, Dense Pipeline Milestones Boost Market Sentiment","url":"https://stock-news.laohu8.com/highlight/detail?id=1111961748","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111961748?lang=en_us&edition=fundamental","pubTime":"2026-09-16 09:51","pubTimestamp":1789523514,"startTime":"0","endTime":"0","summary":"On September 16, HENGRUI PHARMA rose 3.01% in regular trading, trading at HKD 45.0/share, with turnover of HKD 39.16 million. The rally was driven by a rapid succession of pipeline catalysts spanning...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Hengrui Pharma Rises on Multiple Pipeline Milestones","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667648643","title":"BlackRock's Long Position in H-Shares of Jiangsu Hengrui Pharmaceuticals Increases to 7.17% on Sept 10 from 6.56% - HKEX","url":"https://stock-news.laohu8.com/highlight/detail?id=2667648643","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667648643?lang=en_us&edition=fundamental","pubTime":"2026-09-15 17:27","pubTimestamp":1789464478,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nFWN4570BI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0359201885.HKD","LU1781817850.SGD","LU2148510915.USD","LU0359202008.SGD","LU2097828631.EUR","BK0239","LU0359201612.USD","LU1328615791.USD","LU2328871848.SGD","LU1969619763.USD","LU2097828474.EUR","01276","BK0060","LU1997245094.SGD","BK1191","LU1820825898.SGD","LU2580892862.HKD","BK0183","BK0028","LU1023057109.AUD","LU2543165471.USD","LU2495084118.USD","LU1997244956.HKD","LU1655091616.SGD","LU0405327494.USD","BK0012","LU1146622755.USD","LU2289578879.USD","LU1997245177.USD","600276","LU1064131003.USD","LU1580142542.USD","LU0405327148.USD","LU1064130708.USD","LU1255011170.USD","LU2097828714.EUR","LU2097828805.USD","LU2580892789.USD","LU2488822045.USD","BK0196","LU2097828557.USD","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151952155","title":"Jiangsu Hengrui Secures Green Light for HRS-4139 Tablet Clinical Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=1151952155","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151952155?lang=en_us&edition=fundamental","pubTime":"2026-09-15 16:42","pubTimestamp":1789461741,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals Co.,Ltd. (SH: 600276) has announced that its subsidiary, Fujian Shengdi Pharmaceutical Co., Ltd., has received the Drug Clinical Trial Approval Notice from the...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMED","LU2543165471.USD","LU0359202008.SGD","LU2148510915.USD","LU2097828714.EUR","600276","LU1064131003.USD","LU2097828805.USD","LU2289578879.USD","LU2495084118.USD","PSYK","LU1146622755.USD","LU2488822045.USD","BK0196","BK1191","01276","BK0060","LU0359201885.HKD","LU2328871848.SGD","MDTX","LU1328615791.USD","LU0405327148.USD","LU1255011170.USD","LU1781817850.SGD","LU1997245177.USD","LU1023057109.AUD","LU1969619763.USD","LU2097828631.EUR","BK0188","IBBQ","LU2097828557.USD","LU2097828474.EUR","LU0405327494.USD","LU1820825898.SGD","LU2580892862.HKD","IBBJ","LU1997244956.HKD","BK0028","LU1064130708.USD","LU2580892789.USD","BK0239","LU0359201612.USD","BK0012","BK0183","LU1655091616.SGD","LU1997245094.SGD","LU1580142542.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667690619","title":"Chinese Drug Regulator Accepts Hengrui Pharmaceuticals Unit's Marketing Application for SHR-2004 Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=2667690619","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667690619?lang=en_us&edition=fundamental","pubTime":"2026-09-15 10:06","pubTimestamp":1789437982,"startTime":"0","endTime":"0","summary":"China's National Medical Products Administration accepted the drug marketing authorization application of Jiangsu Hengrui Pharmaceuticals'  unit, Beijing Shengdi Pharmaceutical, for SHR-2004 injection, according to a Tuesday disclosure in a Shanghai bourse filing.The drug is used to prevent venous thromboembolism in adult patients undergoing elective knee replacement surgery.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2543165471.USD","LU0359202008.SGD","BK1191","LU0359201885.HKD","01276","LU0359201612.USD","LU1023057109.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667656927","title":"Big Pharma is Pouring Billions into China's Biotechs","url":"https://stock-news.laohu8.com/highlight/detail?id=2667656927","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667656927?lang=en_us&edition=fundamental","pubTime":"2026-09-14 15:59","pubTimestamp":1789372740,"startTime":"0","endTime":"0","summary":"China's biotech industry has become as much a challenger to America's technological leadership as China's artificial intelligence upstarts.Big Pharma firms have cut license deals worth tens of billion","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN8TJ469.HKD","LU1291159041.SGD","SG9999014567.USD","GSKH","SBHMY","LU0463099449.HKD","ZLAB","LU0979878070.USD","LU1116320901.HKD","LU2476274720.SGD","LU0061475181.USD","LU2462157665.USD","LU0348825331.USD","IE0009355771.USD","LU2580892862.HKD","LU0819121731.USD","LU1093756168.USD","LU1941712264.USD","IE00B4R5TH58.HKD","BK4139","LU0882574055.USD","LU2491050071.SGD","LU2112291526.USD","01177","LU1934455194.USD","LU2242646821.SGD","LU1242518931.SGD","LU2495084118.USD","LU0477156953.USD","BK1521","LU1670711040.USD","LU1116320737.USD","LU0114720955.EUR","LU1941712348.USD","GSK","SG9999001176.USD","LU0051755006.USD","09926","LU0327786744.USD","BK4526","LU2023250843.SGD","LU0861579265.USD","LU1226287529.USD","SG9999014542.SGD","LU0348766576.USD","LU1188198961.HKD","LU0588546209.SGD","JDOC","LU0225284248.USD","IE00BZ08YR35.GBP","LU0456855351.SGD","LU1201861249.SGD","BK1191","LU0456827905.SGD","SG9999002463.SGD","LU1226287792.SGD","SG9999014575.USD","LU0265550946.USD","LU0823416689.USD","BK1583","LU0306807586.USD","LU0472753341.HKD","SG9999001440.SGD","LU1880383366.USD","LU2433249047.HKD","LU2125154778.USD","GSK.UK","IE00BZ08YS42.EUR","BK1589","BMED","LU1585245621.USD","LU0516423174.USD","LU1868837300.USD","AZN","IE00B1BXHZ80.USD","LU1066053197.SGD","XLV","IE00BBT3K403.USD","LU0310800379.SGD","LU1032466523.USD","LU1255011170.USD","LU1993786604.SGD","LU1894683264.USD","LU2237443978.SGD","LU1917777945.USD","LU0315179316.USD","LU0321505439.SGD","LU2237443622.USD","LU0432979614.USD","IE00BJT1NW94.SGD","LU2580892789.USD","LU1670710661.SGD","LU1035773651.USD","BK4548","LU0634319403.HKD","LU1074936037.SGD","LU0225771236.USD","IE00BPRC5H50.USD","LU0856984785.SGD","LU0868494617.USD","LU1894683348.USD","LU1571399168.USD","LU1934455277.USD","IE0002270589.USD","LU2289578879.USD","LU1883839398.USD","LU0289739343.SGD","SG9999003800.SGD","LU0096364046.USD","GDOC","LU2360032135.SGD","LU1781817850.SGD","SG9999013999.USD","LU1868836591.USD","SG9999002562.SGD","LU0965508806.USD","LU0516422952.EUR","LU1226287875.USD","LU1061106388.HKD","LU2237443382.USD","LU0456846285.SGD","LU1261432733.SGD","IE00B031HY20.USD","LU2361044865.SGD","LU0203347892.USD","LU0029864427.USD","LU0211331839.USD","LU0106261372.USD","LU2236285917.USD","PAWZ","LU0067412154.USD","HRTS","LU0029874061.USD","SG9999014559.SGD","LU1974910355.USD","BK4533","LU2125909593.SGD","LU3063872942.SGD","LU2778985437.USD","LU0455707207.USD","LU1989772923.USD","SG9999011175.SGD","MRK","LU0321505868.SGD","BK1574","IE0008368742.USD","RXL","LU1720050803.USD","LU0942090050.USD","LU0006306889.USD","LU0501845795.SGD","IE00B2B36J28.USD","LU1688375341.USD","LU2148510915.USD","LU2417539215.USD","LU0181495838.USD","SG9999002232.USD","LU2242652126.USD","AZNH","LU2097828805.USD","LU0234572021.USD","BK1515","LU0348735423.USD","LU0708994859.HKD","WXXWY","LU2456880835.USD","LU0128525929.USD","IE00B5MMRT66.SGD","LU1066051498.USD","LU2097828474.EUR","SG9999015341.SGD","IE00BSNM7G36.USD","BK4007","SMMT","LU1066051811.HKD","BK4599","BK4592","LU0289739699.SGD","LU0109394709.USD","LU1008478684.HKD","LU0122379950.USD","PFE","LU1807302812.USD","BK1161","LU2106854487.HKD","LU1829250122.USD","LU0244354667.USD","LU0267386448.USD","LU0052750758.USD","LU2039709279.SGD","IE00BLSP4452.SGD","LU0985320562.USD","IE00B0JY6N72.USD","LU1997244956.HKD","IE00BFXG1179.USD","BK0239","LU2097828714.EUR","LU0098860793.USD","BK4588","LU0417516902.SGD","HK0000165453.HKD","LU1064131003.USD","SG9999015358.SGD","LU1868836914.USD","01276","LU0140636845.USD","BMY","LU0314109678.HKD","LU0238689110.USD","SG9999002224.SGD","LU1430594728.SGD","LU1037948897.HKD","BK4532","IE00BFTCPJ56.SGD","BK4559","LU1069347547.HKD","LU0359202008.SGD","LU1242518857.USD","LU0502904849.HKD","SG9999001176.SGD","LU0326950275.SGD","LU2328871848.SGD","LU0965509010.AUD","LU0348783233.USD","BK4550","LU0070302665.USD","LU0208291251.USD","LU0170899867.USD","BK4581","LU1236620750.USD","SGXZ57979304.SGD","LU0540923850.HKD","LU1236620834.HKD","LU1226288253.USD","IE00B19Z3B42.SGD","LU1580142542.USD","LU1989771016.USD","600276","BK4568","LU1718418525.SGD","LU2361045086.USD","LU0128526141.USD","LU0130517989.USD","BK0060","LU1037948541.HKD","LU1226288170.HKD","LU1969619763.USD","FHLC","LU0266013472.USD","BK4531","LU1057294990.SGD","LU0516422440.USD","LU0320764599.SGD","LU1923622614.USD","LU0289961442.SGD","LU0307460666.USD","02269","LU2596442595.SGD","KURE","LU1929549753.HKD","LU0823426308.USD","LU1328277881.USD","LU1983299246.USD","LU1960683339.HKD","LU0306806265.USD","LU1831875114.USD","LU0572944931.SGD","IYH","LU0069063385.USD","LU0561508036.HKD","LU2491050154.USD","IE0002141913.USD","LU0058720904.USD","LU0823426480.USD","BK0028","LU0607220059.USD","BK4534","OZEM","LU1162221912.USD","LU2089984988.USD","VHT","LU0348784397.USD","IE00BJJMRZ35.SGD","IE00B19Z3581.USD","01801","IXJ","LU2023250504.SGD","IE00BZ08YT58.USD","LU2237443549.SGD","IE0008369823.USD","BK1576","LU2461242641.AUD","LU0039217434.USD","BK4516","LU0868494708.USD","LU0149534421.HKD","LU0965509283.SGD","LU1868837136.USD","LU1328615791.USD","LU0405327148.USD","09688","LU1951186391.HKD","BK1141","LU0859254822.USD","BK1610","LU1152091168.USD","LU2097828557.USD","LU1989772840.SGD","LU0124676726.USD","LU0880133367.SGD","LU0980610538.SGD","LU1323610961.USD","LU0320765992.SGD","LU2324357040.USD","LU0417516571.SGD","BK0183","LU0130102774.USD","LU2133065610.SGD","01093","LU0203345920.USD","LU0348827113.USD","LU0348767384.USD","LU0689626769.HKD","LU0985481810.HKD","LU0057025933.USD","LU1997245177.USD","LU1066051225.USD","LU0965509101.SGD","LU1699723380.USD","LU2237443895.HKD","IE000M9KFDE8.USD","LU0043850808.USD","FTXH","LU0516423091.SGD","LU1670710588.SGD","LU0648001328.SGD","LU1670711123.USD","LU0320765646.SGD","LU1794554557.SGD","LU0511384066.AUD","LU1655091616.SGD","LU1997245094.SGD","LU2399975544.HKD","PPH","LU2468319806.SGD","LU2125909247.SGD","BK4585","LU1146622755.USD","LU2488822045.USD","LU2125154935.USD","LU0237698245.USD","LU1961090484.USD","LU0516422366.SGD","TRUH","IE00B3T34201.USD","LU2097828631.EUR","IHE","IE00BLSP4239.USD","LU0405327494.USD","LU1934455863.HKD","LU1820825898.SGD","LU1064130708.USD","LU1093756325.SGD","LU2491049909.HKD","LU2361044949.HKD","LU0359201612.USD","BK0012","LU0417516738.SGD","LU1868836757.USD","IE00B543WZ88.USD","LU0889565916.HKD","LU1813983027.USD","LU2357627491.SGD","LU0265550359.USD","LU1152091754.HKD","LU1023059063.AUD","BK0196","LU1267930573.SGD","SG9999004220.SGD","LU0708995583.HKD","BK0188","LU2237443465.HKD","LU2242644610.SGD","LU0320765489.SGD","LU0072913022.USD","LU2476274308.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}]}}